The Phase 3 CagriSema program (REDEFINE 1, 2, REIMAGINE 2) capped cagrilintide at 2.4 mg per week
Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
Support for Bone Health In addition to vitamin D and calcium, a growing body of research supports the use of several nutraceutical ingredients that may help maintain bone mineral density and support overall bone health
GLP-1 Agonists Market size was valued at US$ 37,113.2 billion in 2025 and is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026-2032
Telehealth GLP-1 plans across the market generally run from about $200 to $700 or more monthly, driven by the compound, the tier, and whether the product is branded or compounded
Many compounding pharmacies add vitamins to the semaglutide base to create a combination medication